APIMEDS PHARMACEUTICALS US, INC. Adjustments to Additional Paid in Capital, Warrant Issued
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $139.39 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-05-04.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-14
- APIMEDS PHARMACEUTICALS US, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $161.55K.
- APIMEDS PHARMACEUTICALS US, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-06-30 was $139.39K.
- APIMEDS PHARMACEUTICALS US, INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $139.39K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2025-12-31 | $139.39K 10-K · filed 2026-05-04 | ||
| 2025-09-30 | $161.55K 10-Q · filed 2025-11-12 | $300.94K derived: sum of 2 quarters · filed 2026-08-14 | |
| 2025-06-30 | $139.39K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |